Anil Parwani, MD, PhD,

MBA Professor, Pathology Vice Chair and Director, Anatomic Pathology Director, Pathology Informatics Director, Digital Pathology Shared Resource at The James Cancer Hospital Ohio State University, United States

Email: anil.parwani@osumc.edu

Board Certifications Anatomic and Clinical Pathology, American Board of Pathology

Academic and Medical Appointments 2015-present Vice Chair and Director, Anatomic Pathology, Department of

Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 2015-present Professor, Department of Pathology, The Ohio State University

Wexner Medical Center, Columbus, OH 2015-presentDirector, Digital Pathology Shared Resource, Department of

Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 2015-present Professor, Secondary Appointment, Department of Biomedical

Informatics, The Ohio State University, Columbus, OH

Education and Training 2009-2013 MBA, Joseph M. Katz Graduate School of Business, University of

Pittsburgh, PA 2003-2004 Fellow, Urological Pathology, Department of Pathology, Johns

Hopkins Hospital, Baltimore, MD 1999-2003 Resident, Anatomical and Clinical Pathology, Department of Pathology,

Johns Hopkins Hospital, Baltimore, MD 1995-1999 M.D., Case Western Reserve University, School of Medicine,

Cleveland, OH 1989-1993 Ph.D., Virology, Ohio State University, Wooster, OH

 

Liu Chen, MD, PhD

Professor and Chair; Departments of Pathology and Laboratory Medicine at the Rutgers-Robert Wood Johnson Medical School and Rutgers-New Jersey Medical School Chief of Pathology Service; University Hospital at Newark and RWJ University Hospital at New Brunswick Interim Chief; Division of Cancer Pathology, Cancer Institute of New Jersey (CINJ) Director of the Liver Pathology, United States

Email: chen.liu@rutgers.edu

Dr. Liu is a board-certified GI/liver pathologist and an NIH-funded liver disease investigator. As a physician scientist, he is an expert in viral hepatitis, liver cancer immunotherapy, graft-versus- the host disease and cancer epigenetics. His research team has made significant contributions to the understanding of virus or alcohol-induced carcinogenesis, cancer metastasis, cancer biomarker discovery and novel therapies using small molecules and immunotherapy. His research work has been continuously funded by NIH and other funding agencies. Dr. Liu has published more than 220 peer-reviewed articles and book chapters and has 5 patents and pending applications. As a GI/liver pathologist, he provides expert consultations for both adult and pediatric patients.

 

Jeremy P. Segal, MD, PhD

Director, Genomic and Molecular Pathology Associate Professor of Pathology University of Chicago, United States

Email: jsegal5@bsd.uchicago.edu

Jeremy Segal, MD, PhD is an Associate Professor of Pathology and the Director of the Division of Genomic and Molecular Pathology at The University of Chicago. Dr. Segal received an MD from Weill Cornell Medical College and a PhD in Genetics from Rockefeller University, and completed Anatomic Pathology training at New York Hospital – Weill Cornell and Molecular Genetic Pathology training at the Hospital of the University of Pennsylvania. After training, he worked at the New York Genome Center as Director of Clinical Development and Policy before joining the faculty at the University of Chicago. Dr. Segal specializes in genomics technol- ogies and bioinformatics, and has been chiefly responsible for the development of the Division of Genomic and Molecular Pathology, including creation of the Clinical Genomics Laboratory and development/validation of its oncology testing assays. Test platforms in service at UChicago include large-scale DNA and RNA sequenc- ing systems to support personalized cancer care and clinical trial recruitment. Dr. Segal’s research interests revolve around novel use of genomics technologies to improve diagnostics and drive biomarker development, with current areas of inter- est including minimal residual disease assays and emerging epigenetics applica- tions.

 

Roland Schwarting, MD

Department of Pathology at Cooper University Health Care Professor of Pathology Chairman and Chief, Departments of Pathology Cooper University Health Care President, Cooper Medical Staff Cooper Medical School of Rowan University, United States

Dr. Roland Schwarting, is the Chairman of Pathology and Laboratory Medicine at Cooper University Hospital, and Professor of Pathology at CMSRU. Dr. Schwarting subsequently spent three years at Sloan-Kettering Cancer Center developing tumor markers some of which have US patents and are distributed worldwide. He is President Elect of the Medical Staff of the Cooper Health System, and serves also as the President of the South Jersey Pathology Society. Dr. Schwarting serves as Trustee of Cooper University Hospital. He serves as a Member of Board of Trustees of Cooper University Health Care. Dr. Schwarting finished his residency in pathology in Berlin Germany, and continued as an attending pathologist at Thomas Jefferson University until 2006. He is board-certified in Anatomic and Clini- cal Pathology and Hematopathology. He received his M.D. degree from Kiel University, Germany, in 1981.

Special Interests Hematopathology, flow cytometry, lymphoma